Amanote Research
Register
Sign In
RFLP for SST I (Sac I) at the Human Plasminogen Activator Inhibitor Type 1 (PAI-1) Gene Locus
Nucleic Acids Research
- United Kingdom
doi 10.1093/nar/17.6.2375
Full Text
Open PDF
Abstract
Available in
full text
Categories
Genetics
Date
January 1, 1989
Authors
I. kondo
K. Berg
Publisher
Oxford University Press (OUP)
Related search
Regulation of Programmed Cell Death by Plasminogen Activator Inhibitor Type 1 (PAI-1)
Thrombosis and Haemostasis
Hematology
Genetics of Plasminogen Activator Inhibitor-1 (PAI-1) in a Ghanaian Population
PLoS ONE
Multidisciplinary
Structural and Functional Peculiarities of Plasminogen Activator Inhibitor PAI-1
Biopolymers and Cell
Biochemistry
Genetics
Molecular Biology
Highly Stable Plasminogen Activator Inhibitor Type One (VLHL PAI-1) Protects Fibrin Clots From Tissue Plasminogen Activator-Mediated Fibrinolysis
International Journal of Molecular Medicine
Medicine
Genetics
Human Visceral Adipose Tissue and the Plasminogen Activator Inhibitor Type 1
International Journal of Obesity
Nutrition
Endocrinology
Dietetics
Medicine
Metabolism
Diabetes
Plasminogen Activator Inhibitor-1 (PAI-1): A Molecule at the Crossroads to Cell Survival or Cell Death
Thrombosis and Haemostasis
Hematology
Coordinated Induction of Plasminogen Activator Inhibitor-1 (PAI-1) and Inhibition of Plasminogen Activator Gene Expression by Hypoxia Promotes Pulmonary Vascular Fibrin Deposition.
Journal of Clinical Investigation
Medicine
A New SST 1 RFLP Associated With Human Insulin Receptor Locus
Nucleic Acids Research
Genetics
BCL-1 RFLP at the Human Hepatic Lipase Gene Locus (CIPC)
Nucleic Acids Research
Genetics
